Αναζήτηση Δραστικών

FLUOXETINE

Εμπορικές Ονομασίες

  • LADOSE
    Μορφές: CAPS
    Μορφές: ORAL.SOL
    Μορφές: TAB
  • ZINOVAT
    Μορφές: ORAL.SOL
    Μορφές: EF.TAB
  • DRUGBANK - Fluoxetine
  • indication:

    For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.

  • pharmacology:

  • mechanism:

    Metabolized to norfluoxetine, fluoxetine is a selective serotonin-reuptake inhibitor (SSRI), it blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors. SSRIs bind with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs.

  • toxicity:

    Symptoms of overdose include agitation, restlessness, hypomania, and other signs of CNS excitation. LD<sub>50</sub>=284mg/kg (orally in mice).

  • absorprion:

    72%

  • halflife:

    1 to 3 days

  • roouteelimination:

    The primary route of elimination appears to be hepatic metabolism to inactive metabolites excreted by the kidney.

  • volumedistribution:

  • clearance: